H-DL-Leu-DL-Ser-DL-Lys-DL-Tyr-Gly-Gly-DL-Glu-DL-Cys-DL-Ser-DL-Leu-DL-Glu-DL-His-DL-Asn-DL-xiThr-DL-Cys-DL-xiThr-DL-Tyr-DL-Arg-DL-Lys-DL-Asp-NH2
Internal ID | 8763c2c2-af70-4bf4-a230-a9a43672dac4 |
Taxonomy | Organic Polymers > Polypeptides |
IUPAC Name | 5-[[1-[[1-[[1-[[1-[[1-[[4-amino-1-[[1-[[1-[[1-[[1-[[1-[[6-amino-1-[(1-amino-3-carboxy-1-oxopropan-2-yl)amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-4-[[2-[[2-[[2-[[6-amino-2-[[2-[(2-amino-4-methylpentanoyl)amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-5-oxopentanoic acid |
SMILES (Canonical) | CC(C)CC(C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)N)N |
SMILES (Isomeric) | CC(C)CC(C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)N)N |
InChI | InChI=1S/C96H151N29O33S2/c1-45(2)30-54(99)79(142)120-66(40-126)90(153)112-56(13-8-10-28-98)83(146)116-62(32-49-15-19-52(130)20-16-49)80(143)107-38-71(133)106-39-72(134)109-58(23-25-73(135)136)84(147)122-68(42-159)92(155)121-67(41-127)91(154)115-61(31-46(3)4)86(149)113-59(24-26-74(137)138)85(148)117-64(34-51-37-104-44-108-51)88(151)118-65(35-70(100)132)89(152)124-77(48(6)129)95(158)123-69(43-160)93(156)125-76(47(5)128)94(157)119-63(33-50-17-21-53(131)22-18-50)87(150)111-57(14-11-29-105-96(102)103)81(144)110-55(12-7-9-27-97)82(145)114-60(78(101)141)36-75(139)140/h15-22,37,44-48,54-69,76-77,126-131,159-160H,7-14,23-36,38-43,97-99H2,1-6H3,(H2,100,132)(H2,101,141)(H,104,108)(H,106,133)(H,107,143)(H,109,134)(H,110,144)(H,111,150)(H,112,153)(H,113,149)(H,114,145)(H,115,154)(H,116,146)(H,117,148)(H,118,151)(H,119,157)(H,120,142)(H,121,155)(H,122,147)(H,123,158)(H,124,152)(H,125,156)(H,135,136)(H,137,138)(H,139,140)(H4,102,103,105) |
InChI Key | CESUCQNBEIJPAL-UHFFFAOYSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C96H151N29O33S2 |
Molecular Weight | 2303.50 g/mol |
Exact Mass | 2303.0504056 g/mol |
Topological Polar Surface Area (TPSA) | 1040.00 Ų |
XlogP | -17.10 |
Atomic LogP (AlogP) | -13.57 |
H-Bond Acceptor | 37 |
H-Bond Donor | 39 |
Rotatable Bonds | 77 |
There are no found synonyms. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8935 | 89.35% |
Caco-2 | - | 0.8597 | 85.97% |
Blood Brain Barrier | - | 0.7000 | 70.00% |
Human oral bioavailability | - | 0.7429 | 74.29% |
Subcellular localzation | Mitochondria | 0.6171 | 61.71% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8388 | 83.88% |
OATP1B3 inhibitior | + | 0.9394 | 93.94% |
MATE1 inhibitior | - | 0.8009 | 80.09% |
OCT2 inhibitior | - | 0.5000 | 50.00% |
BSEP inhibitior | + | 0.9573 | 95.73% |
P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
P-glycoprotein substrate | + | 0.8718 | 87.18% |
CYP3A4 substrate | + | 0.7351 | 73.51% |
CYP2C9 substrate | - | 0.5958 | 59.58% |
CYP2D6 substrate | - | 0.8180 | 81.80% |
CYP3A4 inhibition | - | 0.6528 | 65.28% |
CYP2C9 inhibition | - | 0.8360 | 83.60% |
CYP2C19 inhibition | - | 0.8135 | 81.35% |
CYP2D6 inhibition | - | 0.8715 | 87.15% |
CYP1A2 inhibition | - | 0.8703 | 87.03% |
CYP2C8 inhibition | + | 0.8112 | 81.12% |
CYP inhibitory promiscuity | - | 0.9176 | 91.76% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.8800 | 88.00% |
Carcinogenicity (trinary) | Non-required | 0.5776 | 57.76% |
Eye corrosion | - | 0.9856 | 98.56% |
Eye irritation | - | 0.8952 | 89.52% |
Skin irritation | - | 0.7804 | 78.04% |
Skin corrosion | - | 0.9281 | 92.81% |
Ames mutagenesis | - | 0.7100 | 71.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.7109 | 71.09% |
Micronuclear | + | 0.6700 | 67.00% |
Hepatotoxicity | - | 0.5894 | 58.94% |
skin sensitisation | - | 0.8461 | 84.61% |
Respiratory toxicity | + | 0.6778 | 67.78% |
Reproductive toxicity | + | 0.9111 | 91.11% |
Mitochondrial toxicity | + | 0.7750 | 77.50% |
Nephrotoxicity | - | 0.9074 | 90.74% |
Acute Oral Toxicity (c) | III | 0.5949 | 59.49% |
Estrogen receptor binding | - | 0.6219 | 62.19% |
Androgen receptor binding | + | 0.7535 | 75.35% |
Thyroid receptor binding | + | 0.8340 | 83.40% |
Glucocorticoid receptor binding | + | 0.8569 | 85.69% |
Aromatase binding | + | 0.8334 | 83.34% |
PPAR gamma | + | 0.7692 | 76.92% |
Honey bee toxicity | - | 0.6873 | 68.73% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | - | 0.5900 | 59.00% |
Fish aquatic toxicity | + | 0.7743 | 77.43% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 99.97% | 98.95% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.71% | 97.23% |
CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 99.54% | 85.00% |
CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 99.50% | 98.94% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.19% | 83.82% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 99.09% | 96.67% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 99.03% | 90.20% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.64% | 96.09% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 98.63% | 93.10% |
CHEMBL236 | P41143 | Delta opioid receptor | 98.60% | 99.35% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.57% | 100.00% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 98.26% | 99.17% |
CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 98.18% | 88.10% |
CHEMBL3837 | P07711 | Cathepsin L | 97.97% | 96.61% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 97.71% | 88.42% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 97.27% | 98.05% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.63% | 100.00% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.51% | 91.11% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.50% | 94.45% |
CHEMBL3176 | O43603 | Galanin receptor 2 | 96.10% | 98.89% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 95.76% | 98.33% |
CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 95.53% | 94.55% |
CHEMBL2535 | P11166 | Glucose transporter | 95.48% | 98.75% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 94.99% | 82.86% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 94.93% | 97.21% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.34% | 93.56% |
CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 94.31% | 91.81% |
CHEMBL3018 | Q9Y5Y6 | Matriptase | 94.09% | 98.33% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 93.71% | 95.50% |
CHEMBL4801 | P29466 | Caspase-1 | 93.68% | 96.85% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.58% | 96.00% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 93.04% | 99.15% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 92.68% | 93.00% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.48% | 90.71% |
CHEMBL2973 | O75116 | Rho-associated protein kinase 2 | 92.24% | 96.73% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.12% | 96.90% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.66% | 95.00% |
CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 91.10% | 92.29% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 90.94% | 94.75% |
CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 89.64% | 96.37% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 89.43% | 94.62% |
CHEMBL4296013 | Q5VWK5 | Interleukin-23 receptor | 89.39% | 88.00% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 89.18% | 94.00% |
CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 89.12% | 96.03% |
CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 88.80% | 95.17% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 88.44% | 100.00% |
CHEMBL2334 | P42574 | Caspase-3 | 88.36% | 98.25% |
CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 88.33% | 96.28% |
CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 87.77% | 99.77% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.48% | 100.00% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 85.53% | 90.17% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.14% | 95.56% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 85.07% | 95.38% |
CHEMBL3401 | O75469 | Pregnane X receptor | 85.04% | 94.73% |
CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 85.02% | 97.88% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 84.39% | 90.08% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.23% | 95.89% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 84.09% | 92.32% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 83.52% | 96.47% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 83.35% | 97.09% |
CHEMBL3038469 | P24941 | CDK2/Cyclin A | 83.24% | 91.38% |
CHEMBL237 | P41145 | Kappa opioid receptor | 82.70% | 98.10% |
CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 82.64% | 95.52% |
CHEMBL4123 | P30989 | Neurotensin receptor 1 | 82.44% | 96.67% |
CHEMBL4581 | P52732 | Kinesin-like protein 1 | 81.95% | 93.18% |
CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 81.65% | 83.14% |
CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 | 81.57% | 97.53% |
CHEMBL2319 | P06870 | Kallikrein 1 | 81.46% | 90.95% |
CHEMBL3468 | P55210 | Caspase-7 | 81.28% | 95.68% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 80.57% | 97.64% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Piper amalago |
Piper guineense |
PubChem | 139583672 |
LOTUS | LTS0017427 |
wikiData | Q104254359 |